• Home
  • Mutual Funds
  • Tata India Pharma & HealthCare Fund Growth

Return

  • 1M
  • 3M
  • 6M
  • 1Y
  • 3Y
  • 5Y
This Fund:
Sensex:
BankFD:

Showing Funds Performance since Sep 07, 2020

Fund Overview

Min. investment

SIP ₹100 & Lump. ₹5000

AUM (Fund size)

₹1,229 Cr

Lock In Period

N/A

Expense Ratio

2.15

Benchmark

BSE Healthcare Total Return

Exit Load

0.25% of NAV if redeemed/switched out before 30 days from the date of allotment.

Summary

Latest details for Tata India Pharma & HealthCare Fund Growth include a ₹29.5761 NAV as of Apr 22,2026 and returns since inception of 79.31%. Minimum investments start at SIP ₹100. The Tata India Pharma & HealthCare Fund Growth AUM is ₹1,229 Cr, with a lock-in of N/A years, expense ratio of 2.15%, and benchmark BSE Healthcare Total Return. Exit load is - 0.25% of NAV if redeemed/switched out before 30 days from the date of allotment.. In the growth review for 1M Month/Year, the fund recorded 2.99% returns, against a category average of 2.17% and a category best of 3.97%.

Calculate Returns

You would have got

close_grey_icon
No Data Found
Your Investment Amount
  • 1
  • 2
  • 3
  • 4
  • 5

Growth Review

DurationFund Return(%)Category Average(%)Category Best(%)
1M2.992.173.97
6M-5.021.878.52
1Y1.196.088.38
3Y21.4918.07104.94

Portfolio Analysis

  • Equity: 99.69%
  • Debt: 0.31%
  • Others
As on: 2026-03-31
View allocation % by

1. SUN PHARMACEUTICAL INDUSTRIES LTD10.34%
2. ABBOTT INDIA LTD5.89%
3. DIVI LABORATORIES LTD5.83%
4. CIPLA LTD5.10%
5. MANKIND PHARMA LTD3.57%
6. DR REDDYS LABORATORIES LTD3.45%
7. LUPIN LTD3.18%
8. SYNGENE INTERNATIONAL LTD2.64%
9. SAI LIFE SCIENCES LTD2.58%
10. ALKEM LABORATORIES LTD2.45%
11. J.B.CHEMICALS & PHARMACEUTICALS LTD2.40%
12. GLAXOSMITHKLINE PHARMACEUTICALS LTD2.14%
13. NEULAND LABORATORIES LTD2.08%
14. AJANTA PHARMA LTD2.04%
15. FDC LTD1.84%
16. SANOFI INDIA LTD1.70%
17. AUROBINDO PHARMA LTD1.20%
18. TORRENT PHARMACEUTICALS LTD1.10%
19. CORONA REMEDIES LTD0.75%
20. PROCTER & GAMBLE HEALTH LTD0.70%
21. JUBILANT PHARMOVA LTD0.34%
22. IPCA LABORATORIES LTD0.00%

1. HEALTHCARE GLOBAL ENTERPRISES LTD5.39%
2. MAX HEALTHCARE INSTITUTE LTD5.14%
3. APOLLO HOSPITALS ENTERPRISE LTD4.25%
4. RAINBOW CHILDRENS MEDICARE LTD4.23%
5. FORTIS HEALTHCARE LTD3.17%
6. METROPOLIS HEALTHCARE LTD3.02%
7. DR. LAL PATH LABS LTD2.69%
8. GLOBAL HEALTH LTD2.01%
9. VIJAYA DIAGNOSTIC CENTRE LTD1.41%
10. KRISHNA INSTITUTE OF MEDICAL SCIENCES LTD1.34%
11. DR. AGARWALS HEALTH CARE LTD0.07%

1. BAYER CROPSCIENCE LTD3.51%
2. PI INDUSTRIES LTD0.63%
3. SUMITOMO CHEMICAL INDIA LTD0.39%

About Fund

Tata India Pharma & HealthCare Fund Growth managed by Tata Mutual Fund,is a Healthcare & Pharmascheme with Assets Under Management of ₹1,229 Crore. The fund benchmarks its performance against the BSE Healthcare Total Return while maintaining an expense ratio of 2.15. Under the expert guidance of Rajat Srivastava ,the fund implements a disciplined investment approach aligned with its mandate. The scheme requires a minimum investment of ₹500 for SIP and ₹1,000 for lump sum investments, making it accessible to diverse investor profiles.

Fund Managers

Rajat Srivastava

Mr. Rajat Srivastava has done BBA (Banking & Insurance), PGDM - IMT Ghaziabad. Prior to joining Tata Mutual Fund, he has worked with Incred Asset Management, Kotak Investment Banking, Emkay Global, Evalueserve and Motilal Oswal Financial Services.

Peer Comparison

Fund NameRatingsAUMExpense Ratio
This FundDSP Healthcare Fund Growth32891.76 CR1.94
This FundNippon India Pharma Fund Growth47898.24 CR1.82
This FundTata India Pharma & HealthCare Fund Growth21229.42 CR2.15
This FundSBI Healthcare Opportunities Fund Growth34063.64 CR1.93
This FundICICI Prudential Pharma Healthcare & Diagnostics (P.H.D) Fund Growth56293.14 CR1.87
Fund Name1Y3Y
This FundDSP Healthcare Fund Growth0.617574.5953
This FundNippon India Pharma Fund Growth2.368879.0549
This FundTata India Pharma & HealthCare Fund Growth1.192879.3144
This FundSBI Healthcare Opportunities Fund Growth3.543891.5017
This FundICICI Prudential Pharma Healthcare & Diagnostics (P.H.D) Fund Growth4.68299.7934

FAQs

Tata India Pharma & HealthCare Fund Growth's fund is managed by experienced SEBI-registered investment fund manager , who implements the fund's strategy through research-backed decisions while adhering to its stated objectives.

The expense ratio of Tata India Pharma & HealthCare Fund Growth is 2.15. This expense ratio is calculated by dividing the fund's operating expenses by its net assets.

Tata India Pharma & HealthCare Fund Growth’s fund performance is as follows:
  • 1 Month : 2.99%
  • 6 Months : -5.02%
  • 1 Year : 1.19%
  • 3 Years : 21.49%
Returns of Tata India Pharma & HealthCare Fund Growth are updated daily based on NAV of ₹ 29.5761 as on Apr 22,2026. Since inception, the return has been 79.31%.

You can invest in Tata India Pharma & HealthCare Fund Growth through SIP with a minimum of ₹500 monthly or make a lump sum investment of a minimum ₹1,000. Additional purchase minimums vary by scheme.

The fund size (AUM) of Tata India Pharma & HealthCare Fund Growth is ₹1,229 crore. It changes based on market performance, inflows, and outflows.

You can track your investment in Tata India Pharma & HealthCare Fund Growth through our website, our Choice FinX mobile app, regular statements, and email updates. Our customer support team is available for queries.
Min Inv Amount: ₹500